Osteoarthritis

Old Dogs, New Tricks: Is Your Canine In Need Of Cannabis?

Medical Marijuana Can Reduce Use Of Opioid Painkillers For Treating Back Pain & Osteoarthritis

Cannabis For Arthritis: Enveric Biosciences Files Patent On CBD Medication For Osteoarthritis

Medical Marijuana Can Reduce Use Of Opioid Painkillers For Treating Back Pain & Osteoarthritis

Cannabis For Arthritis: Enveric Biosciences Files Patent On CBD Medication For Osteoarthritis

Study: Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis

Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm

Study: Medical Cannabis Use Reduces Opioid Prescriptions in Patients With Osteoarthritis

Virpax Posts Toxicology, Pharmacokinetic Data For Pain Med Epoladerm

EXCLUSIVE: Ampio's Ampion Shows Benefit In Late-Stage Knee Osteoarthritis Study

Sorrento To Start Testing Non-Opioid Candidate In Osteoarthritis-Related Knee Pain

Osteoarthritis Recent News

Can-Fite Stock Gains On Piclidenoson Development Pact For Pets

Galapagos Drops Early Metabolic & Osteoarthritis Programs, Reorganizes R&D Efforts

Pfizer And Eli Lilly's Osteoarthritis Drug Rejected By FDA Panel As Too Risky

An expert panel of the U.S. Food and Drug Administration has rejected Pfizer Inc.

Pfizer/Eli Lilly's Tanezumab Safety Profile Fails To Impress FDA Even After 15 Years Of Development Across 41 Trials

Ahead of an advisory committee meeting scheduled for later this week, the FDA released its in-depth review of Pfizer Inc (NYSE: PFE) and Eli Lilly And Co’s (N

Flexion To Test Higher Dose Of FX201 Gene Therapy In Early-Stage Osteoarthritis Study

Zynebra Pharmaceuticals Receives International Patent For Osteoarthritis Treatment With CBD Gel

Sorrento's Knee Pain Medication Found Safe, Effective Based On Early Data

Catalysts Growing Like Weeds For Zynerba Next Quarter

It's High Time For Zynerba Positives: Investors Await 3 Key Mid-Stage Trial Reads On Cannabidiol ZYN002